You are here

Focal atrophy and cerebrovascular disease increase dementia risk among cognitively normal older adults.

TitleFocal atrophy and cerebrovascular disease increase dementia risk among cognitively normal older adults.
Publication TypeJournal Article
Year of Publication2007
AuthorsRosano, C, Aizenstein, HJ, Wu, M, Newman, AB, Becker, JT, Lopez, OL, Kuller, LH
JournalJ Neuroimaging
Volume17
Issue2
Pagination148-55
Date Published2007 Apr
ISSN1051-2284
KeywordsAged, Alzheimer Disease, Analysis of Variance, Atrophy, Cerebrovascular Disorders, Cognition, Female, Humans, Logistic Models, Longitudinal Studies, Magnetic Resonance Imaging, Male, Risk Factors, Temporal Lobe, United States
Abstract<p><b>BACKGROUND AND PURPOSE: </b>This study investigated the association of medial temporal lobe (MTL) atrophy and cerebrovascular disease (white matter hyperintensities [WMH], subclinical infarcts) with the risk of developing Alzheimer's disease (AD) among cognitively normal older adults.</p><p><b>METHODS: </b>Risk of developing AD was examined for 155 cognitively normal older adults (77.4 years, 60% women, 81% white). The MTL volumes and the presence of WMH and of subclinical infarcts were determined from brain magnetic resonance imaging (MRI) at the beginning of the study. Follow-up cognitive evaluations (average 4.3 years) identified those who developed AD.</p><p><b>RESULTS: </b>The presence of either MTL atrophy or subclinical infarcts was independently and significantly associated with a greater risk to develop AD (OR [95% CI]: 4.4 [1.5, 12.3] and 2.7 [1.0, 7.1], respectively). In addition, those participants with both MTL atrophy and at least one brain infarct had a 7-fold increase in the risk of developing AD (OR [95% CI]: 7.0 [1.5, 33.1]), compared to those who had neither of these conditions.</p><p><b>CONCLUSIONS: </b>In cognitively normal older adults, markers of neurodegeneration (as reflected by MTL atrophy) and of cerebrovascular disease (as reflected by infarcts on MRI) independently contribute to the risk to develop AD.</p>
DOI10.1111/j.1552-6569.2007.00093.x
Alternate JournalJ Neuroimaging
PubMed ID17441836
Grant ListN01 HC-15103 / HC / NHLBI NIH HHS / United States
N01-HC-35129 / HC / NHLBI NIH HHS / United States
N01-HC-85079 / HC / NHLBI NIH HHS / United States
N01-HC-85086 / HC / NHLBI NIH HHS / United States
R01AG015928 / AG / NIA NIH HHS / United States
R01AG020098 / AG / NIA NIH HHS / United States
T32 AG00181-11 / AG / NIA NIH HHS / United States